Candyflipping, or simultaneously consuming LSD and MDMA, has been a thing since the hazy club days of the early 1980s, but the combination of these two drugs has never been studied in a clinical setting. Until now, that is.

Researchers from New York City-based psychedelic drug development startup Mind Medicine, Inc. have just launched a new study to explore the interactions between LSD and MDMA. The company is about to kick off its Phase 1 trial, which is intended to show that the combination of these two drugs can be safely tolerated by healthy subjects. If this trial is successful, researchers can move on to a Phase 2 study, which will focus on the potential benefits of candyflipping.

While several recent studies on LSD have focused on microdosing, the present study will be giving subjects a powerful psychedelic dose. Each of the 24 subjects in the trial will either receive a placebo or a combination of 100 μg of LSD and 100 mg of MDMA, a dosage high enough to trigger the full effects of each of these drugs. 

But despite the strong dose, the researchers told ZME Science that they’re “not developing this so people can have a better rave.” The end goal of this research is to create a specific hallucinogenic treatment that would be used as an adjunct to therapy. Mind Medicine founder and CEO JR Rahn said that he envisions a semi-regular psychedelic treatment, rather than requiring patients to stay “on a pill a day for the rest of your life.”

According to anecdotal reports, LSD increases the potency and duration of MDMA’s effects, allowing users to sustain the ecstasy experience without taking more pills and risking an overdose. Of course, the full hallucinogenic effects of acid also remain in effect, but some users have found that the MDMA can reduce the risk of a “bad trip.”

Prior research on MDMA has found that it can induce feelings of empathy and trust, and when combined with therapy, can help patients overcome PTSD, trauma- related issues, or addiction. Mind Medicine is also conducting clinical trials to determine whether microdoses of LSD can treat anxiety or ADHD, and other researchers are exploring whether acid can help break addictions, reduce acute pain, or treat Alzheimer’s symptoms.

After decades of prohibiting all entheogenic drugs, the US government has finally been swayed by this new wave of psychedelics research. The Food and Drug Administration has granted both MDMA and psilocybin “Breakthrough Therapy” status, allowing researchers to fast-track clinical studies with an aim to eventually legalize both of these drugs as an adjunct to therapy. LSD has yet to receive this designation, but that may soon change, considering the growing body of research into its therapeutic potential. 

Read More

The study seeks to determine the effects of feeding hemp to cattle, with a specific focus on determining if it might result in human food products that contain dangerous or intoxicating concentrations of cannabinoids. In other words, scientists are looking to see if eating a hemp-fed hamburger might get you high.

The USDA touted the grant via Twitter, stating that the study’s results would help set policies regarding the use of hemp in animal feed. Even though hemp has been legal to cultivate since 2018, feeding it to livestock remains prohibited. The project is also notable because little is known regarding the effects of cannabinoids on cattle, as such research most often involves trials with humans, mice, and pigs.

“Our goal is to fill in the knowledge gaps,” said Michael Kleinhenz, a member of the KSU research team. “Until feedstuffs containing hemp are established as safe in animals, our data will assist producers in managing situations involving intentional or unintentional hemp exposures.”

Preliminary studies have determined that cows can easily absorb and process hemp. The next step is determining what happens when humans eat and process those same cows.

“We don’t believe that the degree of absorption is sufficient for us to be concerned about potential intoxication following the consumption of meat and milk,” KSU’s Hans Coetzee told WKSN-TV. “If we can prove that that is of no concern of consequence to the consumer, we feel that that would remove one of the major impediments to the widespread production of hemp worldwide.”

As hemp prohibition continues to crumble all over the planet, many farmers hope they’ll be able to use the leftover parts of the plants to feed their animals. The KSU study is one major step in determining the safety of that practice and it could lead to a major boost in the global hemp business — and maybe even some happier cattle.

Read More

Flower Or Concentrates: Which Do Cannabis Consumers Prefer?

Even though cannabis concentrates are rising in popularity, new data says that many marijuana users prefer to smoke flower. Despite technology and the much touted strength of cannabis concentrates, a large percentage of marijuana users prefer to stick to the classics. A new report published in the journal Drug and Alcohol Dependence found that about […]

The post Flower Or Concentrates: Which Do Cannabis Consumers Prefer? appeared first on The Fresh Toast.

Read More
Call Now
Are you 21 or older? This website requires you to be 21 years of age or older. Please verify your age to view the content, or click "Exit" to leave.
Enable Notifications Yes, please keep me updated No thanks
Skip to toolbar